C1 Esterase Inhibitor (Human) (Berinert)
C1 Esterase Inhibitor (Human) is an FDA-licensed reference biologic from CSL Behring GmbH.
Reference product
Berinert C1 Esterase Inhibitor (Human)
CSL Behring GmbH
View full reference-product record- Approved
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Molecular structure
Experimental 3D structure for C1 Esterase Inhibitor (Human) from the RCSB Protein Data Bank (PDB 5DU3).
Interactive biological assembly from PDB entry 5DU3. Drag to rotate, scroll to zoom, and inspect the full atomic structure right here, with no need to leave the page.
Exclusivity & patent cliffs
Reference approval
Approval date of the reference C1 Esterase Inhibitor (Human) product.
17 yr 2 mo ago
Orphan exclusivity ends
7-year orphan-drug exclusivity window.
10 yr 1 mo ago
C1 Esterase Inhibitor (Human): frequently asked questions
Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.
Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for C1 Esterase Inhibitor (Human).
Related FDA reference tools
- FDA Orange BookApproved drugs, generics, therapeutic-equivalence codes, patents, and exclusivity.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
